2014
DOI: 10.3109/15563650.2014.918627
|View full text |Cite
|
Sign up to set email alerts
|

Seizures after single-agent overdose with pharmaceutical drugs: Analysis of cases reported to a poison center

Abstract: CONTEXT Seizures during intoxications with pharmaceuticals are a well-known complication. However, only a few studies report on drugs commonly involved and calculate the seizure potential of these drugs. OBJECTIVES To identify the pharmaceutical drugs most commonly associated with seizures after single-agent overdose, the seizure potential of these pharmaceuticals, the age-distribution of the cases with seizures and the ingested doses. METHODS A retrospective review of acute single-agent exposures to pharmaceu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
29
1
3

Year Published

2015
2015
2018
2018

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(33 citation statements)
references
References 34 publications
0
29
1
3
Order By: Relevance
“…Case reports and case series suggest that certain secondgeneration agents, notably citalopram, venlafaxine, and bupropion, as well as selected antipsychotic medications, might be more hazardous in overdose (11)(12)(13)(14)(15)(16)(17)(18)(19). However, few reports have systematically compared the morbidity and mortality of the array of agents used to treat depression.…”
mentioning
confidence: 99%
“…Case reports and case series suggest that certain secondgeneration agents, notably citalopram, venlafaxine, and bupropion, as well as selected antipsychotic medications, might be more hazardous in overdose (11)(12)(13)(14)(15)(16)(17)(18)(19). However, few reports have systematically compared the morbidity and mortality of the array of agents used to treat depression.…”
mentioning
confidence: 99%
“…The remarkable potential of tolperisone to cause seizures in overdose was also described in another study from our centre, and was shown to be comparable with that of tramadol, mefenamic acid, citalopram, and venlafaxine. 16 The observed cardiovascular symptoms were predominantly mild, although there was a case of relevant prolongation of the QTc-interval (500 ms), and this has not been previously reported in the literature. The product information reports a case of unspecified QT-interval prolongation, which was observed in combination with a supraventricular and ventricular arrhythmia after the ingestion of 750 mg of tolperisone in a 11-month-old child.…”
Section: Discussionmentioning
confidence: 73%
“…There are human cases and animal models that attempt to characterize this adverse effect. 7,[14][15][16][17][18][19][20] In a rat and a mouse model, TRA, its enantiomers, and active metabolite were shown to induce seizures in rats with a lowered seizure threshold and at a seizure dose to antinociceptive dose ratio similar to that of codeine. 14,15 TRA has structural similarities and may possess some antidepressant activity similar to venlafaxine, which has been associated with seizures in several studies.…”
Section: Discussionmentioning
confidence: 99%